If you have been reading about AOD-9604 and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-06-25. Numbers and descriptions here follow the published literature rather than marketing material.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine | Status varies by country; prohibited in sport. |
| Common storage temperature | 2–8 °C for lyophilized powder | Protect from light and moisture; follow supplier instructions. |
| Typical analytical method | LC-MS/MS | Used for identification and quantification in biological samples. |
| Purity assessment | HPLC and mass spectrometry | Reverse-phase HPLC is common for peptide purity. |
| Common synonyms | AOD9604; hGH 176-191 fragment | Naming conventions differ across studies. |
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
A qullqa (Quechua pronunciation: [ˈqʊʎˌqa] "deposit, storehouse"; (spelling variants: colca, collca, qolca, qollca) was a storage building found along roads and near the cities and political centers of the Inca Empire. These were large stone buildings with roofs thatched with "ichu" grass, or what is known as Peruvian feathergrass (Jarava ichu). To a "prodigious [extent] unprecedented in the annals of world prehistory" the Incas stored food and other commodities which could be distributed to their armies, officials, conscripted laborers, and, in times of need, to the populace. The uncertainty of agriculture at the high altitudes which comprised most of the Inca Empire was among the factors which probably stimulated the construction of large numbers of qullqas.
=== Amateur === Lisa has been weight training since 2003 and has been conditioning for competitive entry since 2008. She first really got into bodybuilding in 2006 while she was living in Japan while she was teaching English. Her boyfriend at the time was a Japanese bodybuilding champion and she started reading up on bodybuilding, such as Negrita Jayde, and started training with weights. In 2007, after she got married, she went to see the 2007 Ms. Olympia competition for their honeymoon and was impressed when she saw female bodybuilders for the first time. Former UK junior champion Lewis Breed oversees her training and pre-contest preparation for bodybuilding. She competed in her debut competition at the 2009 NABBA England, placing second place behind Jennie Ellam. She then competed at the 2009 NABBA Universe achieving second place to Larissa Cunha. Her best win was first place at the UKBFF British Championships, where she won the Ladies Physique class. On 19 March 2014, she announced that she had been awarded her IFBB pro card and can now compete as a pro.
=== In-universe marketing === By mid-2021, Amazon created Vought International account across social media platforms such as YouTube, Facebook, Instagram, Twitter, and TikTok as part of their strategy for an innovative viral marketing campaign of The Boys. Most of the published posts are faux news, music videos, announcements, commercials, and propaganda regarding Vought and the Seven with many of the commentaries being written like if it were from the people that actually lived in the fictional world. Due to the satirical nature of the series, the marketing campaign approach is intended to touch into the "corporate greed and corruption and how celebrity is weaponized to mask accountability", while some of the posts also portray the in-universe consequences of the events occurred through the series, intending to make critique towards capitalism as well as the social and political issues surrounding America in modern times, while also making parodies of not only the superhero industry but also the studios behind it such as Disney. Wanting to satirize the pop culture and make a reflection over the real-world issues, Amazon opted to get a meta-approach and character-driven marketing campaign for the series to make the audience question over what is real or not and ensure the fans become immersed on the series themes and conflicts with the characters, leading to weekly discussions between them during the third season's run and attract global attention all around the globe.
Dried Tenebrio molitor larvae (mealworms) with the Commission Implementing Regulation (EU) 2021/882 of 1 June 2021 (in force on 22 June 2021). Frozen, dried and powdered forms of migratory locust (Locusta migratoria) with the Commission Implementing Regulation (EU) 2021/1975 of 12 November 2021 (in force on 5 December 2021). Frozen, dried and powdered forms of house cricket (Acheta domesticus) with the Commission Implementing Regulation (EU) 2022/188 of 10 February 2022. Frozen, paste, dried and powder forms of lesser mealworm larvae (Alphitobius diaperinus) with the Commission Implementing Regulation (EU) 2023/58 of 5 January 2023.
=== Less severe forms === A less severe, related disease, partial HPRT deficiency, is known as Kelley–Seegmiller syndrome (Lesch–Nyhan syndrome involves total HPRT deficiency). Symptoms generally involve less neurological involvement but the disease still causes gout and kidney stones.
Sources: en.wikipedia.org
=== Hitler government and new elections === Meanwhile, Papen had formed an intrigue to oust his successor. He conferred with Hugenberg and industrial magnates and bankers during a feverish night in which the outcome was unclear to all participants. On 30 January 1933 Hitler was appointed Chancellor with Papen as Vice-Chancellor and Hugenberg as minister for economics. Though seeing their adversaries Papen and Hugenberg join forces with Hitler, the Centre Party still did not give up building a broad coalition government. Since the new administration was still lacking a majority in parliament, the Centre was ready to support it, either by toleration or by coalition. Hitler intended to minimise non-Nazi participation, but feigned a willingness to cooperate with the Centre and blamed Papen and Hugenberg for denying cabinet posts to the Centre. When Kaas requested a broad outline of his government's objectives, Hitler used the questionnaire presented by Kaas to declare the talks a failure and obtain the President's approval for calling for new elections for the third time in about half a year. These elections in March 1933 were already marred by the SA's terror, after the Reichstag fire and civil rights had been suspended by President Hindenburg through the Reichstag Fire Decree. Still the Centre Party campaigned hard against the Hitler administration and managed to preserve their former vote of roughly 11 per cent. The government parties NSDAP and DNVP however jointly won 52 per cent of the vote.
Superoxide dismutase (or alternatively, myeloperoxidase) generates hydrogen peroxide from superoxide. Hydroxyl radicals are then generated via the Haber–Weiss reaction or the Fenton reaction, of which are both catalyzed by Fe2+. In the presence of halide ions, prominently chloride ions, myeloperoxidase uses hydrogen peroxide to produce hypochlorous acid. Nitric oxide synthase (the inducible isoform, iNOS, in immunity) catalyses the production of nitric oxide from L-arginine. Nitric oxide may react with superoxide anions to produce peroxynitrite anion.
GC–MS of amphetamine and methamphetamine with the chiral derivatizing agent Mosher's acid chloride allows for the detection of both dextroamphetamine and dextromethamphetamine in urine. Hence, the latter method may be used on samples that test positive using other methods to help distinguish between the various sources of the drug.
== Function == All interferons share several common effects: they are antiviral agents and they modulate functions of the immune system. Administration of Type I IFN has been shown experimentally to inhibit tumor growth in animals, but the beneficial action in human tumors has not been widely documented. A virus-infected cell releases viral particles that can infect nearby cells. However, the infected cell can protect neighboring cells against a potential infection of the virus by releasing interferons. In response to interferon, cells produce large amounts of an enzyme known as protein kinase R (PKR). This enzyme phosphorylates a protein known as eIF-2 in response to new viral infections; the phosphorylated eIF-2 forms an inactive complex with another protein, called eIF2B, to reduce protein synthesis within the cell. Another cellular enzyme, RNAse L—also induced by interferon action—destroys RNA within the cells to further reduce protein synthesis from both viral and host genes. Inhibited protein synthesis impairs both virus replication and infected host cells. In addition, interferons induce production of hundreds of other proteins—known collectively as interferon-stimulated genes (ISGs)—that have roles in combating viruses and other actions produced by interferon. They also limit viral spread by increasing p53 activity, which kills virus-infected cells by promoting apoptosis. The effect of IFN on p53 is also linked to its protective role against certain cancers.
=== Smoking === Smoking tobacco has been shown to increase caffeine clearance by 56% as a result of polycyclic aromatic hydrocarbons inducing the CYP1A2 enzyme. The CYP1A2 enzyme that is induced by smoking is responsible for the metabolism of caffeine; increased enzyme activity leads to increased caffeine clearance, and is associated with greater coffee consumption for regular smokers.
Sources: en.wikipedia.org
The complement component 1q (or simply C1q) is a protein complex involved in the complement system, which is part of the innate immune system. C1q together with C1r and C1s form the C1 complex. Antibodies of the adaptive immune system can bind antigen, forming an antigen-antibody complex. When C1q binds antigen-antibody complexes, the C1 complex becomes activated. Activation of the C1 complex initiates the classical complement pathway of the complement system. The antibodies IgM and all IgG subclasses except IgG4 are able to initiate the complement system.
The number of 60Fe atoms per unit area found on Earth can be estimated if the typical amount of 60Fe ejected from a supernova is known. This can be done by dividing the surface mass density (Σej) by the atomic mass of 60Fe.
=== Economics === In the United States, as of 2015, the cost is between US$1,284 and US$1,386 per 30 mcg vial. As of 2020, the National Average Drug Acquisition Cost (NADAC) in the United States for Avonex was $6,872.94 for a 30 mcg kit. Avonex and Rebif are on the top ten best-selling multiple sclerosis drugs of 2013. It is an example of a specialty drug that would only be available through a specialty pharmacy. This is because it requires a refrigerated chain of distribution and costs $17,000 a year.
). Thus, the number of free parameters in the NCM model always exceeds the number of homologous characters in the data matrix, and the NCM model has been criticized as consistently "over-parameterized."
Soap solutions, cosmetics, and toothpaste Food such as butter, cheese, jam, mayonnaise, soup, and yogurt Natural substances such as gums, protein solutions, and extracts Biological fluids such as blood, saliva, semen, mucus, and synovial fluid agricultural waste, magma, and lava, Slurries such as cement slurry and paper pulp,
Sources: en.wikipedia.org
No major regulatory agency has approved AOD-9604 as a medicine. It is treated as an experimental peptide in research settings. Some countries restrict its sale or import.
The World Anti-Doping Agency classifies growth hormone fragments, including AOD-9604, as prohibited substances. The classification reflects concern about potential performance-enhancing use. Athletes are subject to testing for such peptides.
Detection typically uses liquid chromatography combined with mass spectrometry. These methods separate the peptide and identify it by mass. Immunoassays may screen samples but require confirmation by a more specific technique.
Yes, the World Anti-Doping Agency classifies AOD-9604 as a prohibited peptide hormone and related substance. Its use by athletes is banned under the relevant anti-doping code.